TITLE

Acute viscerotropic disease following vaccination against yellow fever

AUTHOR(S)
Hayes, Edward B.
PUB. DATE
October 2007
SOURCE
Transactions of the Royal Society of Tropical Medicine & Hygiene;Oct2007, Vol. 101 Issue 10, p967
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Summary: Acute viscerotropic disease following yellow fever vaccination (YEL-AVD) is a rare but serious complication of vaccination with 17D yellow fever vaccine. This paper reviews the existing literature regarding YEL-AVD and discusses possible etiologic mechanisms. A greater understanding of this condition is essential to assuring safe and effective prevention of yellow fever and vaccination against other arboviral diseases for which 17D-based vaccines are being developed.
ACCESSION #
26413763

 

Related Articles

  • Pathogenic epitopes, heterologous immunity and vaccine design. Welsh, Raymond M.; Fujinami, Robert S. // Nature Reviews Microbiology;Jul2007, Vol. 5 Issue 7, p555 

    Substantial research has been directed towards the development of a new generation of vaccines that are based on the inclusion of immunogenic epitopes in recombinant vectors. Here we examine the evidence that under certain conditions immunogenic epitopes can do more harm than good and might...

  • Routine vaccines across the life span, 2005. Zimmerman, Richard Kent; Middleton, Donald B.; Burns, Ilene Timko; Clover, Richard D.; Kimmel, Sanford R. // Journal of Family Practice;Jan2005 Supplement, Vol. 54, pS9 

    Routine vaccines include those listed on the Recommended Childhood and Adolescent Immunization Schedule and the Recommended Adult Immunization Schedule. The disease burden, rationale for vaccination, efficacy, adverse reactions, and recommendations are discussed in relation to each vaccine....

  • Vaccines for persons at high risk due to medical conditions, occupation, environment, or lifestyle, 2005. Zimmerman, Ricahrd Kent; Middleton, Donald B. // Journal of Family Practice;Jan2005 Supplement, Vol. 54, pS27 

    The rates of morbidity and mortality due to influenza and pneumococcal diseases are high among persons with underlying medical conditions; thus, influenza and pneumococcal polysaccharide vaccines are recommended for those with cardiac disease, diabetes mellitus, chronic obstructive pulmonary...

  • Public interest or public menace? Smith, Patty // Alive: Canada's Natural Health & Wellness Magazine;Sep2005, Issue 275, p50 

    Comments on public belief about the capacity of vaccines to prevent diseases. Implication of the belief for scientists and policy-makers involved in vaccination programs; Evidence supporting claims about risks associated with vaccines; Continuation of mass vaccination despite questions about its...

  • Vaccination coverage and timeliness in three South African areas: a prospective study. Fadnes, Lars T.; Jackson, Debra; Engebretsen, Ingunn M. S.; Zembe, Wanga; Sanders, David; Sommerfelt, Halvor; Tylleskär, Thorkild // BMC Public Health;2011 Supplement 4, Vol. 11 Issue Suppl 4, p404 

    Background: Timely vaccination is important to induce adequate protective immunity. We measured vaccination timeliness and vaccination coverage in three geographical areas in South Africa. Methods: This study used vaccination information from a community-based cluster-randomized trial promoting...

  • In the mood for wiping out vaccine-preventable diseases. Fleck, Fiona // Bulletin of the World Health Organization;Apr2014, Vol. 92 Issue 4, p236 

    An interview with executive vice president of the Sabin Vaccine Institute, Ciro de Quadros, is presented. He discusses how he became interested in immunization while involved with a smallpox programme in Brazil in 1969, what disease surveillance and containment is and how he helped to develop...

  • Meningococcal Vaccines. Rüggeberg, Jens U.; Pollard, Andrew J. // Pediatric Drugs;2004, Vol. 6 Issue 4, p251 

    Meningococcal disease is one of the most feared and serious infections in the young and its prevention by vaccination is an important goal. The high degree of antigenic variability of the organism makes the meningococcus a challenging target for vaccine prevention. Meningococcal polysaccharide...

  • Dynamics of HPV vaccination initiation in Flanders (Belgium) 2007-2009: a Cox regression model. Lefevere, Eva; Hens, Niel; De Smet, Frank; Van Damme, Pierre // BMC Public Health;2011 Supplement 4, Vol. 11 Issue Suppl 4, p470 

    Background: We investigated dynamic patterns and predictors of HPV vaccination initiation in Flanders (Belgium) by girls aged 12 to 18, between 2007 and 2009, the period immediately after the introduction of the HPV vaccines on the Belgian market. During this period the initiative for...

  • Serologic Cross-Reactivity of Human IgM and IgG Antibodies to Five Species of Ebola Virus. MacNeil, Adam; Reed, Zachary; Rollin, Pierre E. // PLoS Neglected Tropical Diseases;Jun2011, Vol. 5 Issue 6, p1 

    Five species of Ebola virus (EBOV) have been identified, with nucleotide differences of 30-45% between species. Four of these species have been shown to cause Ebola hemorrhagic fever (EHF) in humans and a fifth species (Reston ebolavirus) is capable of causing a similar disease in non-human...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics